Press Releases

Month Year

Month Year

Aug 12, 2014

Insmed Announces Pricing of Public Offering of Common Stock

Read more
Aug 6, 2014

Insmed Reports Second Quarter 2014 Financial Results

Read more
Aug 4, 2014

Insmed Provides Regulatory Update for ARIKAYCE

Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications

Read more
Jun 20, 2014

Insmed to Present at the JMP Securities Healthcare Conference

Read more
May 29, 2014

Insmed Appoints David R. Brennan to Its Board of Directors

Read more
May 20, 2014

Insmed Announces Positive Open Label Data from Phase 2 Clinical Trial of ARIKAYCE for Treatment Resistant Nontuberculous Mycobacterial Lung Infections

Poster Presentation at the American Thoracic Society Annual Meeting 2014

Read more
May 13, 2014

Insmed Announces Data Presentations for ARIKAYCE in Two Orphan Lung Diseases at the American Thoracic Society Meeting

Read more
May 12, 2014

Insmed to Participate in the Bank of America Merrill Lynch 2014 Health Care Conference

Read more
May 8, 2014

Insmed Reports First Quarter 2014 Financial Results

Read more
Apr 7, 2014

Insmed to Participate in the 13th Annual Needham & Co. Healthcare Conference

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation